Sindi Ikhlas A, Dodd Peter R
Centre for Psychiatry & Clinical Neuroscience, School of Medicine, Australia.
Neurodegener Dis Manag. 2015;5(2):137-45. doi: 10.2217/nmt.14.54.
Synaptic damage is a key hallmark of Alzheimer's disease and the best correlate with cognitive decline ante mortem. Signature protein combinations arrayed at tightly apposed pre- and post-synaptic sites characterize different types of synapse. Neuroligins are postsynaptic cell adhesion molecules that interact with neurexins across the synaptic cleft. These pairings recruit receptors, channels and signal transduction molecules to the synapse, and help mediate trans-synaptic transmission. Dysfunction in the neuroligin family can disrupt neuronal networks and leads to neurodegeneration and other diseases. The extracellular domain of neuroligins is homologous with acetylcholinesterase but lacks residues required for enzymatic activity. This domain may interact pathogenically with β-amyloid. Here we summarize research over the last decade on the potential involvement of neuroligins in Alzheimer's disease.
突触损伤是阿尔茨海默病的关键标志,也是生前认知能力下降的最佳关联因素。排列在紧密相邻的突触前和突触后位点的标志性蛋白质组合表征了不同类型的突触。神经连接蛋白是突触后细胞粘附分子,可通过突触间隙与神经配素相互作用。这些配对将受体、通道和信号转导分子招募到突触,并有助于介导跨突触传递。神经连接蛋白家族的功能障碍会破坏神经网络,导致神经退行性变和其他疾病。神经连接蛋白的细胞外结构域与乙酰胆碱酯酶同源,但缺乏酶活性所需的残基。该结构域可能与β-淀粉样蛋白发生致病性相互作用。在此,我们总结了过去十年中关于神经连接蛋白在阿尔茨海默病中潜在作用的研究。